Affluent Medical S.A.
PAR: AFME.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Sebastien Ladet
- Employees
- 66
- Headquarters
- Aix-en-Provence, France
- IPO year
- 2021
- Market cap
- €110.4M
- Website
- https://www.affluentmedical.com
Loading AFME…
Loading profile data…Frequently asked questions about AFME
What does Affluent Medical S.A. (AFME.PA) do?
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the tr...
Where does AFME.PA trade?
Affluent Medical S.A. (AFME.PA) trades on the Euronext Paris.
What sector is AFME.PA in?
Affluent Medical S.A. (AFME.PA) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Affluent Medical S.A.?
Sebastien Ladet is the chief executive officer of Affluent Medical S.A. (AFME.PA).
Where is Affluent Medical S.A. headquartered?
Affluent Medical S.A. is headquartered in France.
Does AFME.PA pay a dividend?
Affluent Medical S.A. (AFME.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AFME.PA go public?
Affluent Medical S.A. (AFME.PA) completed its initial public offering in 2021.